Indication
Cerebral thromboembolism prevention
Cerebral thromboembolism prevention refers to therapeutic strategies aimed at averting the formation and migration of blood clots that can occlude the cerebral arterial circulation. Read more about Cerebral thromboembolism prevention
252 drugs 136 manufacturers
Drugs that treat it
Common Cerebral thromboembolism prevention therapies.
ASPIRIN EC (aspirin)
ASPIRIN EC (aspirin)
CLOPIDOGREL (clopidogrel bisulfate)
WARFARIN SODIUM
CLOPIDOGREL (clopidogrel bisulfate)
CLOPIDOGREL (clopidogrel bisulfate)
ASPIRIN EC (aspirin)
CLOPIDOGREL (clopidogrel bisulfate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCerebral thromboembolism prevention refers to therapeutic strategies aimed at averting the formation and migration of blood clots that can occlude the cerebral arterial circulation.
This clinical goal primarily targets populations vulnerable to ischemic cerebrovascular events, such as patients with atrial fibrillation, mechanical heart valves, severe carotid atherosclerosis, or a prior history of transient ischemic attack or embolic stroke.
Pathophysiologically, the condition being prevented involves the disruption of intracranial perfusion when an intraluminal thrombus—originating from cardiac chambers, major proximal arteries, or paradoxical venous sources—dislodges and lodges in downstream cerebral vessels.
Without intervention, these occlusive events precipitate acute cerebral ischemia, cytotoxic edema, and irreversible neurological deficits characteristic of acute ischemic infarction.
- mayoclinic.org
Cerebral thromboembolism prevention refers to therapeutic strategies aimed at averting the formation and migration of blood clots that can occlude the cerebral arterial circulation This clinical goal primarily targets populations vulnerable to ischemic cerebrovascular events, such as patients with atrial fibrillation, mechanical heart valves, severe carotid atherosclerosis, or a prior history of transient ischemic attack or embolic stroke Pathophysiologically, the condition being prevented invol...
- uth.edu
Cerebral thromboembolism prevention refers to therapeutic strategies aimed at averting the formation and migration of blood clots that can occlude the cerebral arterial circulation This clinical goal primarily targets populations vulnerable to ischemic cerebrovascular events, such as patients with atrial fibrillation, mechanical heart valves, severe carotid atherosclerosis, or a prior history of transient ischemic attack or embolic stroke Pathophysiologically, the condition being prevented invol...
- nih.gov
This clinical goal primarily targets populations vulnerable to ischemic cerebrovascular events, such as patients with atrial fibrillation, mechanical heart valves, severe carotid atherosclerosis, or a prior history of transient ischemic attack or embolic stroke
- bmj.com
Without intervention, these occlusive events precipitate acute cerebral ischemia, cytotoxic edema, and irreversible neurological deficits characteristic of acute ischemic infarction
Personalize your experience
Follow Cerebral thromboembolism prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.